Table 11. Receipt of antiretroviral therapy by HIV-infected women and HIV exposed infants, by timing of receipt, race/ethnicity, and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas | Enhanced Perinatal Surveillance—Participating Areas in the United States and Dependent Areas, 2000–2003 | Reports | Statistics and Surveillance | Topics

Home

About CDC

Press Room

A-Z Index

CDC en Español

CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Enhanced Perinatal Surveillance—Participating Areas in the United States and Dependent Areas, 2000–2003

Table 11. Receipt of antiretroviral therapy by HIV-infected women and HIV exposed infants, by timing of receipt, race/ethnicity, and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas

View PDF


	Year of infant's birth								Cumulative total
	2000		2001		2002		2003		Cumulative total
Receipt of antiretroviral therapy	No.	%	No.	%	No.	%	No.	%	No.	%
	White, not Hispanic
Prenatal period
Yes	303	83	314	88	196	84	136	87	949	86
No	46	13	29	8	25	11	19	12	119	11
Unknown	14	4	13	4	11	5	2	1	40	4

Intrapartum period^a
Yes	177	82	238	86	200	90	132	84	747	85
No	31	14	27	10	17	8	21	13	96	11
Unknown	10	5	13	5	6	3	4	3	33	4

Neonatal period^b
Yes	334	92	336	94	219	94	150	96	1,039	94
No	23	6	7	2	8	3	4	3	42	4
Unknown	6	2	13	4	5	2	3	2	27	2

Total	363		356		232		157		1,108
	Black, not Hispanic
Prenatal period
Yes	1,853	79	1,603	79	1,040	80	808	81	5,304	80
No	376	16	342	17	173	13	148	15	1,039	16
Unknown	102	4	75	4	79	6	42	4	298	4

Intrapartum period^c
Yes	1,227	79	1,175	79	1,022	82	837	84	4,261	80
No	271	17	260	17	198	16	140	14	869	16
Unknown	58	4	56	4	33	3	21	2	168	3

Neonatal period^d
Yes	2,165	93	1,865	92	1,224	95	954	96	6,208	93
No	116	5	87	4	45	3	27	3	275	4
Unknown	50	2	68	3	23	2	17	2	158	2

Total	2,331		2,020		1,292		998		6,641
	Hispanic
Prenatal period
Yes	487	81	423	84	344	85	375	88	1,629	84
No	88	15	62	12	42	10	34	8	226	12
Unknown	25	4	20	4	21	5	15	4	81	4

Intrapartum period^d
Yes	395	80	368	83	340	84	379	89	1,482	84
No	77	16	58	13	56	14	39	9	230	13
Unknown	22	4	19	4	10	2	6	1	57	3

Neonatal period^b
Yes	556	93	475	94	383	94	408	96	1,822	94
No	30	5	25	5	14	3	3	1	72	4
Unknown	14	2	5	1	10	2	13	3	42	2

Total	600		505		407		424		1,936
	Asian/Pacific Islander
Prenatal period
Yes	21	84	8	67	12	86	12	100	53	84
No	3	12	3	25	1	7	0	0	7	11
Unknown	1	4	1	8	1	7	0	0	3	5

Intrapartum period^e
Yes	15	75	7	78	12	86	12	100	46	84
No	4	20	2	22	1	7	0	0	7	13
Unknown	1	5	0	0	1	7	0	0	2	3

Neonatal period^b
Yes	23	92	11	92	13	93	12	100	59	94
No	2	8	1	8	0	0	0	0	3	5
Unknown	0	0	0	0	1	7	0	0	1	2
Total	25		12		14		12		63

Note. Because of rounding, column percentages may not total to 100 percent. American Indian/Alaska Native excluded due to small numbers. See Table 4 for cumulative totals of all races. 234 cases excluded due to unknown race/ethnicity.


^a	Excludes 232 cases with missing information.
^b	Includes 1 HIV-exposed infant per pregnancy with the assumption that all infants of multiple birth received the same antiretroviral therapy.
^c	Excludes 1,343 cases with missing information.
^d	Excludes 167 cases with missing information.
^e	Excludes 8 cases with missing information.

Next: Table 12

Last Modified: January 5, 2009
Last Reviewed: January 5, 2009
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Home

Policies and Regulations

Disclaimer

e-Government

FOIA

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.

Department of Health
and Human Services